# Predicting Neoadjuvant Therapy Response of Rectal Cancer With MRI

> **NCT02640586** · NA · UNKNOWN · sponsor: **Sun Ying-Shi** · enrollment: 1614 (actual)

## Conditions studied

- Rectal Neoplasms

## Interventions

- **DEVICE:** three MR examination

## Key facts

- **NCT ID:** NCT02640586
- **Lead sponsor:** Sun Ying-Shi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01-10
- **Primary completion:** 2020-07-17
- **Final completion:** 2023-12-31
- **Target enrollment:** 1614 (ACTUAL)
- **Last updated:** 2023-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02640586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02640586, "Predicting Neoadjuvant Therapy Response of Rectal Cancer With MRI". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT02640586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*